MK-677 Half-Life and Duration: What It Means for Your Dosing

MK-677 at a glance:

• Drug class: Oral non-peptide ghrelin receptor agonist (development discontinued for FDA approval)
• Route: oral
• Typical frequency: once daily
• Half-life: approximately 4-6 hours

The half-life of MK-677 (approximately 4-6 hours) is the single most important number for understanding why it's dosed the way it is. Below we unpack the practical implications.

Half-Life Defined

The half-life is the time it takes for the concentration of a drug in the bloodstream to fall by half. It governs how often a drug needs to be dosed to maintain therapeutic levels and how long the drug persists after the last dose.

For MK-677, the half-life is approximately 4-6 hours. That number explains the once daily dosing schedule.

Time to Steady State

After starting (or changing) a dose, drug levels reach a new "steady state" after about 5 half-lives.

For MK-677: practical steady state takes ~5x the half-life listed above. That's why dose changes don't show their full effect immediately.

How Long MK-677 Stays in Your System

A common question: "if I stop MK-677, how long does it stay in my body?"

The standard rule of thumb is that a drug is essentially cleared after 5 half-lives. For MK-677: that's approximately 30 hours. Effects on appetite, glucose, or other targets persist for a similar period before fully resolving.

For this compound, downstream effects depend on the cellular pathways involved.

Practical Implications

A long half-life:

• Allows less frequent dosing (better adherence)
• Smooths out peaks and troughs (often better tolerability)
• Means dose changes take longer to fully express
• Creates a longer "runway" if a dose is missed

A short half-life:

• Requires more frequent dosing
• Produces sharper concentration peaks (and matching side effects)
• Allows faster dose adjustments
• Provides faster clearance if stopped

MK-677, with its short half-life, falls on the short end of this spectrum.

Half-Life and Missed Doses

If a dose is missed:

• Take the missed dose as soon as you remember if you're well within the dosing interval
• Skip it if you're closer to the next dose
• Never double up

The longer the half-life, the more forgiving the missed-dose window. For MK-677, timing matters more.

Half-Life Across the Drug Class

Within the broader class of oral non-peptide ghrelin receptor agonist (development discontinued for fda approval), half-lives vary significantly. Half-life variation across the class affects dosing frequency and tolerability profiles. See our comparison pages for direct comparisons.

Bottom Line

The approximately 4-6 hours half-life of MK-677 is what makes its once daily schedule work. Shorter half-lives need more frequent dosing; longer ones offer more flexibility.

Frequently Asked Questions

Related Reading

• The Honest Guide to MK-677: What Patients and Doctors Actually Say
• Is MK-677 Safe? An Honest Look at the Side-Effect Profile
• MK-677 Outcomes Decoded: Who Responds Best and Why
• Why MK-677 Costs So Much (and 5 Ways to Pay Less)
• CJC-1295 101: A Plain-English Guide for 2026
• MK-677 Cycle and Protocol: What Researchers Actually Use

Sources

• Teichman SL et al. Prolonged Stimulation of Growth Hormone (GH) and Insulin-Like Growth Factor I Secretion by CJC-1295. JCEM 2006;91:799.
• Stanley TL et al. Effects of Tesamorelin on Visceral Fat in HIV-Infected Patients With Lipodystrophy. NEJM 2010;363:2425.
• Nass R et al. Effects of an Oral Ghrelin Mimetic on Body Composition in Healthy Older Adults. Annals of Internal Medicine 2008;149:601.

This page is informational only and is not medical advice.